Credit: ABITEC.

Donald Kelemen, PhD profile page

Chief Scientific Officer

at ABITEC Corporation

Dr. Donald Kelemen is chief scientific officer at ABITEC Corporation, a global leader in lipid chemistry and formulation technologies for pharmaceutical and nutritional applications. Dr. Kelemen oversees the development of high-purity lipids and custom excipients that support a wide range of advanced therapeutic platforms, including lipid nanoparticles (LNPs). He holds a PhD in Nutrition and Biotechnology and has over 20 years of experience in the pharmaceutical industry.

Got a Question for Donald Kelemen, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Donald Kelemen, PhD

Total: 1

Illustration of an orange cancer cell being targeted by light blue immune cells.

Industry Insight

Lipid-Based Systems’ Potential To Transform CAR T Therapy for Solid Tumors

In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the reach of CAR T-cell therapies into solid tumor indications.